TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ACTU

Actuate Therapeutics, Inc.

Healthcare · Biotechnology

0.7316$ -9.4% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ACTU
Line item 2022 2023 2024 2025
0.00 0.00 0.00 0.00
1.09 1.44 0.96 0.49
0.25 0.22 0.33 0.58
1.34 1.66 1.29 1.07
-1.34 -1.66 -1.29 -1.07
0.00 0.00 0.00 0.00
-1.34 -1.65 -1.40 -1.06
– – 0.00 0.00
-1.34 -1.65 -1.40 -1.06
-1.34 -1.62 -1.29 -1.06

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?